{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Kenagy RD"],"funding":["NHLBI NIH HHS","National Institutes of Health","CSRD VA"],"pagination":["202-209.e6"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4627903"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["64(1)"],"pubmed_abstract":["Objective
Approximately 30% of autogenous vein grafts develop luminal narrowing and fail because of intimal hyperplasia or negative remodeling. We previously found that vein graft cells from patients who later develop stenosis proliferate more in vitro in response to growth factors than cells from patients who maintain patent grafts. To discover novel determinants of vein graft outcome, we have analyzed gene expression profiles of these cells using a systems biology approach to cluster the genes into modules by their coexpression patterns and to correlate the results with growth data from our prior study and with new studies of migration and matrix remodeling.Methods
RNA from 4-hour serum- or platelet-derived growth factor (PDGF)-BB-stimulated human saphenous vein cells obt"],"journal":["Journal of vascular surgery"],"pubmed_title":["Scavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency."],"pmcid":["PMC4627903"],"funding_grant_id":["R00 HL121172","P01 HL030568","K99 HL121172","HL-30946","HL-30568","R01 HL030946","T32 HL069766","I01 CX000712"],"pubmed_authors":["Kikuchi S","Civelek M","Chen L","Clowes AW","Sobel M","Lusis AJ","Kenagy RD","Grieff A"],"additional_accession":[]},"is_claimable":false,"name":"Scavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency.","description":"Objective
Approximately 30% of autogenous vein grafts develop luminal narrowing and fail because of intimal hyperplasia or negative remodeling. We previously found that vein graft cells from patients who later develop stenosis proliferate more in vitro in response to growth factors than cells from patients who maintain patent grafts. To discover novel determinants of vein graft outcome, we have analyzed gene expression profiles of these cells using a systems biology approach to cluster the genes into modules by their coexpression patterns and to correlate the results with growth data from our prior study and with new studies of migration and matrix remodeling.Methods
RNA from 4-hour serum- or platelet-derived growth factor (PDGF)-BB-stimulated human saphenous vein cells obt","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Jul","modification":"2025-04-04T01:29:22.117Z","creation":"2019-03-27T02:01:06Z"},"accession":"S-EPMC4627903","cross_references":{"pubmed":["25935274"],"doi":["10.1016/j.jvs.2014.12.052"]}}